International Business Machines Valuation
Is IBM * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IBM * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: IBM * (MX$4363) is trading below our estimate of fair value (MX$5108.93)
Significantly Below Fair Value: IBM * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IBM *?
Other financial metrics that can be useful for relative valuation.
What is IBM *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | n/a |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.9x |
Enterprise Value/EBITDA | 16.5x |
PEG Ratio | 2.9x |
Price to Earnings Ratio vs Peers
How does IBM *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 30.4x | ||
ACN Accenture | 31.8x | 9.5% | US$225.3b |
TCS Tata Consultancy Services | 31.7x | 10.1% | ₹15.0t |
INFY Infosys | 28.4x | 8.4% | ₹7.7t |
HCLTECH HCL Technologies | 29.9x | 9.3% | ₹5.1t |
IBM * International Business Machines | 30.6x | 10.5% | Mex$195.0b |
Price-To-Earnings vs Peers: IBM * is expensive based on its Price-To-Earnings Ratio (30.6x) compared to the peer average (30.4x).
Price to Earnings Ratio vs Industry
How does IBM *'s PE Ratio compare vs other companies in the Global IT Industry?
Price-To-Earnings vs Industry: IBM * is expensive based on its Price-To-Earnings Ratio (30.6x) compared to the Global IT industry average (23.4x).
Price to Earnings Ratio vs Fair Ratio
What is IBM *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 30.6x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate IBM *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$4,363.00 | Mex$4,408.65 +1.0% | 18.3% | Mex$5,351.16 | Mex$2,860.81 | n/a | 18 |
Nov ’25 | Mex$4,220.00 | Mex$4,343.36 +2.9% | 18.3% | Mex$5,271.92 | Mex$2,818.45 | n/a | 18 |
Oct ’25 | Mex$4,330.00 | Mex$3,858.70 -10.9% | 15.1% | Mex$4,903.30 | Mex$2,726.23 | n/a | 18 |
Sep ’25 | Mex$3,975.00 | Mex$3,580.53 -9.9% | 13.7% | Mex$4,217.07 | Mex$2,469.45 | n/a | 19 |
Aug ’25 | Mex$3,599.00 | Mex$3,472.38 -3.5% | 14.2% | Mex$4,135.88 | Mex$2,421.91 | n/a | 19 |
Jul ’25 | Mex$3,150.00 | Mex$3,231.05 +2.6% | 13.4% | Mex$3,862.95 | Mex$2,335.74 | n/a | 19 |
Jun ’25 | Mex$2,805.00 | Mex$3,058.63 +9.0% | 13.9% | Mex$3,648.66 | Mex$2,206.17 | n/a | 18 |
May ’25 | Mex$2,890.00 | Mex$3,119.25 +7.9% | 12.9% | Mex$3,658.83 | Mex$2,212.31 | n/a | 18 |
Apr ’25 | Mex$3,100.00 | Mex$3,097.40 -0.08% | 15.6% | Mex$3,731.62 | Mex$2,082.38 | n/a | 18 |
Mar ’25 | Mex$3,200.00 | Mex$3,092.78 -3.4% | 15.2% | Mex$3,828.94 | Mex$2,136.69 | n/a | 19 |
Feb ’25 | Mex$3,160.00 | Mex$3,050.06 -3.5% | 16.3% | Mex$3,827.38 | Mex$2,135.81 | n/a | 19 |
Jan ’25 | Mex$2,768.00 | Mex$2,574.00 -7.0% | 14.9% | Mex$3,565.84 | Mex$1,867.82 | n/a | 17 |
Dec ’24 | Mex$2,720.80 | Mex$2,558.48 -6.0% | 11.2% | Mex$3,126.06 | Mex$1,921.04 | n/a | 16 |
Nov ’24 | Mex$2,594.56 | Mex$2,654.86 +2.3% | 11.3% | Mex$3,252.14 | Mex$1,998.52 | Mex$4,220.00 | 16 |
Oct ’24 | Mex$2,525.00 | Mex$2,510.12 -0.6% | 12.0% | Mex$3,212.96 | Mex$1,879.92 | Mex$4,330.00 | 16 |
Sep ’24 | Mex$2,514.80 | Mex$2,473.33 -1.6% | 10.3% | Mex$2,996.07 | Mex$1,883.24 | Mex$3,975.00 | 15 |
Aug ’24 | Mex$2,420.00 | Mex$2,435.59 +0.6% | 10.0% | Mex$2,947.12 | Mex$1,852.48 | Mex$3,599.00 | 16 |
Jul ’24 | Mex$2,288.20 | Mex$2,398.13 +4.8% | 8.4% | Mex$2,787.92 | Mex$1,893.03 | Mex$3,150.00 | 14 |
Jun ’24 | Mex$2,250.00 | Mex$2,470.63 +9.8% | 8.3% | Mex$2,884.04 | Mex$1,958.30 | Mex$2,805.00 | 14 |
May ’24 | Mex$2,329.40 | Mex$2,508.20 +7.7% | 8.3% | Mex$2,912.74 | Mex$1,977.79 | Mex$2,890.00 | 14 |
Apr ’24 | Mex$2,350.90 | Mex$2,715.56 +15.5% | 9.0% | Mex$3,105.83 | Mex$2,070.55 | Mex$3,100.00 | 15 |
Mar ’24 | Mex$2,327.00 | Mex$2,693.84 +15.8% | 8.9% | Mex$3,072.47 | Mex$2,048.31 | Mex$3,200.00 | 15 |
Feb ’24 | Mex$2,501.55 | Mex$2,693.84 +7.7% | 8.9% | Mex$3,072.47 | Mex$2,048.31 | Mex$3,160.00 | 15 |
Jan ’24 | Mex$2,725.00 | Mex$2,782.34 +2.1% | 9.2% | Mex$3,255.47 | Mex$2,190.04 | Mex$2,768.00 | 15 |
Dec ’23 | Mex$2,865.00 | Mex$2,784.37 -2.8% | 8.5% | Mex$3,174.13 | Mex$2,202.05 | Mex$2,720.80 | 15 |
Nov ’23 | Mex$2,698.31 | Mex$2,784.37 +3.2% | 8.5% | Mex$3,174.13 | Mex$2,202.05 | Mex$2,594.56 | 15 |
Analyst Forecast: Target price is less than 20% higher than the current share price.